Harry M. Lever, MD, FACP, FACC

Expert Publications

• The role of echocardiography in assessing the morphological response of left ventricular thrombus to anticoagulation.
• Comparison by real-time three-dimensional echocardiography of left ventricular geometry in hypertrophic cardiomyopathy versus secondary left ventricular hypertrophy.
• Percutaneous transluminal septal myocardial ablation.
• Percutaneous transluminal alcohol septal myocardial ablation after aortic valve replacement.
• Cardiac tamponade masking clinical presentation and hemodynamic effects of papillary muscle rupture after acute myocardial infarction.
• Improvement in diastolic intraventricular pressure gradients in patients with HOCM after ethanol septal reduction.
• Images in cardiovascular medicine. Epicardial real-time 3-dimensional echocardiography during septal myectomy for obstructive hypertrophic cardiomyopathy.
• Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation.
• Role of invasive evaluation with cineradiography and intracardiac echocardiography to detect mechanical prosthetic valve dysfunction.
• Imaging phenotype versus genotype in hypertrophic cardiomyopathy.
• Diversity of mitral valve abnormalities in obstructive hypertrophic cardiomyopathy.
• Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.
• Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes.
• Left ventricular hypertrophy in persons age 90 years and older.
• Determinants of left ventricular hypertrophy in patients with aortic stenosis.

Media Releases

Navigating Cardiac Health with Precision and Compassion

Dr. Harry M. Lever, MD, FACP, FACC, is a seasoned cardiologist recently retired from the Cleveland Clinic in Cleveland, Ohio. His areas of specialization include echocardiography and hypertrophic cardiomyopathy, having previously served as Medical Director of the Hypertrophic Cardiomyopathy Center at Cleveland Clinic.

With over five decades of experience under his belt, Dr. Lever has been instrumental in educating patients and physicians alike on the quality variances that exist between generic and brand name drugs. He emphasizes that generic drugs are not always identical to their brand name counterparts and underscores the lack of rigorous scrutiny that foreign generics undergo compared to drugs in the United States.

His journey towards becoming a leading authority in cardiology began with his graduation from the University of Pittsburgh School of Medicine in 1971. Following this, Dr. Lever completed his residency in internal medicine at UPMC Medical Education from 1971 to 1974 and his fellowship in cardiovascular disease at the University of Rochester from 1973 to 1976.

His credentials include being recognized as a Diplomate of the American Board of Internal Medicine (board certified in internal medicine and cardiovascular disease), a Fellow of the American College of Physicians (FACP), and as a Fellow of the American College of Cardiology (FACC).

Beyond his professional achievements, Dr. Lever is known for his passion for model trains, which serves as a testament to his attention to detail and dedication in all aspects of his life. His commitment to patient safety and advocacy for informed healthcare decisions make him a respected figure in the medical community and a trusted resource for those seeking clarity on medication and heart-related issues.

Recommended Articles

• Treatment for Atrial Fibrillation

  Atrial fibrillation (also called AFib) is a heart arrhythmia infection. It causes sporadic electrical signals within the atria, affecting heart rate. This is referred to as rapid ventricular rate (RVR). Atrial fibrillation derives from unusual electrical impulses within the heart.Factors to consider...

• Too Much Sitting May Increase the Chance of Dying

  Too Much Sitting May Increase the Chance of Dying “Spending too much time sitting may increase the odds of dying due to any cause”, says a new study published in the Archives of Internal Medicine. The chances of dying from any cause increases by as much as 40% in people who spend a lot of time...

• What Is an Arrhythmia?

  An arrhythmia is the violations of the frequency, rhythm, and sequence of heart contractions.Why do arrythmias occur?...

• What Is Pituitary Dwarfism?

  IntroductionPituitary dwarfism, also called growth hormone deficiency, is a medical condition wherein the pituitary gland does not produce sufficient amounts of growth hormone. This deficiency often results in children’s slow growth or short stature.An adult with pituitary dwarfism has an average...

• Ovary Removal Does Not Raise Your Risk for Heart Disease

  A review of data from a major women’s health study failed to find a significant association between ovary removal during a hysterectomy and an increased risk of heart disease. This is in contrast to the results published from another large study that reported that the risk of heart disease...

• Vitamin E May Not Prevent Heart Failure in Women

  According to a new study, vitamin E supplementation may not reduce the risk of heart failure in women. This study is the first of its kind, focusing on the effectiveness of vitamin E supplementation in the prevention of heart failure. Vitamin E is an antioxidant that helps to protect the body from...